收藏切换
Research on the effects of itraconazole on the pharmacokinetics of ADC189 and its metabolite ADC189-I07
收藏切换
PDF
Ning CHEN1, 2, Jin-mei ZHOU1, 2, Yu PENG1, 2, Dao-lei ZHOU1, 2, Xue-mei LOU1, 2, Yu-jie LÜ1, 2, Huan ZHOU1, 2
Chinese Journal of Clinical Pharmacology | 2026, 42(1) : 107 - 111
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(1): 107-111
Pharmacokinetics and Bioequivalence Study
Research on the effects of itraconazole on the pharmacokinetics of ADC189 and its metabolite ADC189-I07
Full
Ning CHEN1, 2, Jin-mei ZHOU1, 2, Yu PENG1, 2, Dao-lei ZHOU1, 2, Xue-mei LOU1, 2, Yu-jie LÜ1, 2, Huan ZHOU1, 2
Affiliations
  • 1.Clinical Trial Research Center, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, Anhui Province, China
  • 2.Anhui Provincial Joint Key Laboratory for Pharmaceutical Research and Clinical Evaluation of Innovative Drugs, Bengbu 233000, Anhui Province, China
Published: 2026-01-17 doi: 10.13699/j.cnki.1001-6821.2026.01.017
Outline
收藏切换
Objective

To evaluate the effects of itraconazole capsules on the pharmacokinetics of a single oral dose of ADC189 and its metabolite ADC189-I07 in Chinese healthy subjects, and to assess the safety of their co-administration.

Methods

This was a single-center, open-label, non-randomized, two-period, fixed-sequence trial, using itraconazole as an inhibitor of cytochrome P450 3A4 (CYP3A4), P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). Analyze the impact of repeated administration of itraconazole capsules on the pharmacokinetic characteristics of ADC189 and its major metabolite ADC189-I07.

Results

After co-administration of ADC189 with itraconazole, there was no difference in the maximum plasma concentration (Cmax) of the active metabolite ADC189-I07 in plasma compares with ADC189 alone; the geometric mean ratio was 106.64%, with a 90% confidence interval (CI) of 84.12%-135.16%. The area under the curve (AUC0-t) and AUC0-∞ increased by approximately 42.00% and 47.00%, respectively, with geometric mean ratios and 90% confidence intervals of 142.48% (120.84%-167.98%) and 147.25% (123.95%-174.91%), respectively. The 90% CIs for all three parameters did not fall entirely within the no-effect boundary of 80.00%-125.00%. The median time to peak drug concentration (tmax) of ADC189-I07 was 4.00 (3.00-4.00) after administration alone and 4.00 (3.00-12.00) h after co-administration; non-parametric tests showed no statistically significant difference in tmax (P>0.05). All adverse events (AEs) during the trial were grade 1 or 2, resolved spontaneously, and the safety risk was controllable.

Conclusion

When ADC189 tablets are used clinically with a strong CYP3A4 inhibitor, no dosage adjustment is required for concomitant use.

itraconazole capsule  /  ADC189  /  ADC189-I07  /  pharmacokinetic
Ning CHEN, Jin-mei ZHOU, Yu PENG, Dao-lei ZHOU, Xue-mei LOU, Yu-jie LÜ, Huan ZHOU. Research on the effects of itraconazole on the pharmacokinetics of ADC189 and its metabolite ADC189-I07[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (1) : 107 -111 . DOI: 10.13699/j.cnki.1001-6821.2026.01.017
Year 2026 volume 42 Issue 1
PDF
138
30
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.01.017
  • Receive Date:2025-10-21
  • Online Date:2026-08-06
  • Published:2026-01-17
Article Data
Affiliations
History
  • Received:2025-10-21
Funding
Affiliations
    1.Clinical Trial Research Center, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, Anhui Province, China
    2.Anhui Provincial Joint Key Laboratory for Pharmaceutical Research and Clinical Evaluation of Innovative Drugs, Bengbu 233000, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.01.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT